These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Prognostic factors of cutaneous melanoma in relation to metastasis at the sentinel lymph node: a case-controlled study. Sartore L; Papanikolaou GE; Biancari F; Mazzoleni F Int J Surg; 2008 Jun; 6(3):205-9. PubMed ID: 18417434 [TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy and survival in elderly patients with cutaneous melanoma. Koskivuo I; Hernberg M; Vihinen P; Virolainen S; Talve L; Seppänen M; Vahlberg T; Jahkola T Br J Surg; 2011 Oct; 98(10):1400-7. PubMed ID: 21638276 [TBL] [Abstract][Full Text] [Related]
11. Lymphatic invasion detected by D2-40/S-100 dual immunohistochemistry does not predict sentinel lymph node status in melanoma. Petitt M; Allison A; Shimoni T; Uchida T; Raimer S; Kelly B J Am Acad Dermatol; 2009 Nov; 61(5):819-28. PubMed ID: 19836642 [TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy in melanoma delays recurrence but does not change melanoma-related survival: a retrospective analysis of 673 patients. Gutzmer R; Al Ghazal M; Geerlings H; Kapp A Br J Dermatol; 2005 Dec; 153(6):1137-41. PubMed ID: 16307648 [TBL] [Abstract][Full Text] [Related]
13. The survival benefit to patients with positive sentinel node melanoma after completion lymph node dissection may be limited to the subgroup with a primary lesion Breslow thickness greater than 1.0 and less than or equal to 4 mm (pT2-pT3). Nowecki ZI; Rutkowski P; Michej W Ann Surg Oncol; 2008 Aug; 15(8):2223-34. PubMed ID: 18506535 [TBL] [Abstract][Full Text] [Related]
15. Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes. van Akkooi AC; Nowecki ZI; Voit C; Schäfer-Hesterberg G; Michej W; de Wilt JH; Rutkowski P; Verhoef C; Eggermont AM Ann Surg; 2008 Dec; 248(6):949-55. PubMed ID: 19092339 [TBL] [Abstract][Full Text] [Related]
17. [Viewpoint of the Dutch Melanoma Working Group regarding sentinel lymph node biopsy: prognostic but not therapeutic implications]. Kruit WH; Ned Tijdschr Geneeskd; 2008 Mar; 152(10):574-6. PubMed ID: 18402325 [TBL] [Abstract][Full Text] [Related]
18. Outcome in 846 cutaneous melanoma patients from a single center after a negative sentinel node biopsy. Yee VS; Thompson JF; McKinnon JG; Scolyer RA; Li LX; McCarthy WH; O'Brien CJ; Quinn MJ; Saw RP; Shannon KF; Stretch JR; Uren RF Ann Surg Oncol; 2005 Jun; 12(6):429-39. PubMed ID: 15886905 [TBL] [Abstract][Full Text] [Related]
19. The prognostic importance of sentinel lymph node biopsy in thin melanoma. Ranieri JM; Wagner JD; Wenck S; Johnson CS; Coleman JJ Ann Surg Oncol; 2006 Jul; 13(7):927-32. PubMed ID: 16788753 [TBL] [Abstract][Full Text] [Related]
20. Clinical considerations on sentinel node biopsy in melanoma from an Italian multicentric study on 1,313 patients (SOLISM-IMI). Testori A; De Salvo GL; Montesco MC; Trifirò G; Mocellin S; Landi G; Macripò G; Carcoforo P; Ricotti G; Giudice G; Picciotto F; Donner D; Di Filippo F; Soteldo J; Casara D; Schiavon M; Vecchiato A; Pasquali S; Baldini F; Mazzarol G; Rossi CR; Ann Surg Oncol; 2009 Jul; 16(7):2018-27. PubMed ID: 19132446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]